The Business Times

Singapore pharmaceuticals

Companies & Markets

iX Biopharma raises gross proceeds of S$6.7 million from placement

iX Biopharma has proposed a placement of new shares in the company at S$0.10 apiece.
Companies & Markets

iX Biopharma proposes placement to raise gross proceeds of at least S$5 million as it eyes US expansion

A strategic tie-up with a US company could lead to the monetisation of 22 drugs under development by September 2026, iX Biopharma said.
Companies & Markets

iX Biopharma shares jump 35% on potential US, Australia listing plans

Singapore mainly exports active pharmaceutical ingredients to the US, instead of finished products like tablets and capsules. Between 2022 and 2024, Singapore’s pharmaceutical exports to the US averaged S$3.7 billion per year.
Singapore

Singapore-based pharma companies waiting for confirmation of US tariff exemptions: MTI

Pharmaceutical exports to the US account for about S$4 billion of the Republic’s exports, says Deputy Prime Minister Gan Kim Yong.
Singapore

New US pharmaceutical tariffs may have ‘no immediate impact’ on drugmakers: DPM Gan

Less-than-favourable valuations for biopharma companies may be a key reason behind the lack of such companies listing on the SGX.
Singapore

The biopharma scene in Singapore is vibrant, but few make it to SGX

Pharmaceutical firms that have broken ground on US facilities will receive exemptions.
Singapore

Trump’s pharma tariffs put Singapore at ‘greatest risk’ among major exporters if no exemptions granted: economists

Interest in medical aesthetics is expanding throughout the region, with specialised clinics opening throughout Asean markets, said Hyphens Pharma chief executive officer Lim See Wah.
Companies & Markets
TOPLINE

Hyphens Pharma bets big on Asean’s medical aesthetics boom

Economists expect a pullback in H2, as front-loading momentum dissipates.
Singapore

Economists, MTI cautious on Singapore’s H2 growth despite full-year forecast upgrade

The Ministry of Trade and Information said it confirmed this understanding with the Office of the US Trade Representative.
Singapore

MTI confirms that Singapore remains subject to 10% baseline tariff on exports to US

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More